|
시장보고서
상품코드
1463763
세계의 연구용 항체 및 시약 시장 : 시장 규모, 점유율 분석(제품별, 종류별, 업종별, 원료별, 형상별, 기술별, 용도별, 최종사용자별) - 산업 수요 예측(-2030년)Research Antibodies and Reagents Market Size and Share Report by Product, Type, Vertical, Source, Form, Technology, Application, End User - Global Industry Demand Forecast to 2030 |
||||||
주요 하이라이트
세계의 연구용 항체·시약 시장은 2023년에 120억 달러, 2030년에는 187억 달러 규모에 달하며, 6.7%의 CAGR로 성장할 전망입니다.
임상 진단·캐리어 스크리닝·신약에 대한 요구의 증가와 유전성 질환의 급증이 업계의 성장을 지원하고 있습니다.
주요 인사이트
시약 카테고리는 2023년에 약 60%로 최대 점유율을 차지하고 있으며, 이 10년간은 이 동향이 계속될 전망입니다.
1차 항체는 2023년에 약 70%의 점유율로 업계를 선도하며, 앞으로도 계속 선도할 전망입니다.
암영역은 2023년 시점에 약 35%로 최대 점유율을 차지하며 주요 지역에서 암이환율이 증가하고 있는 것으로 인해 이 10년간 최대를 유지할 전망입니다.
북미는 2023년에 약 55%의 점유율로 업계를 선도하고 있으며, 바이오테크놀러지와 의약품의 연구개발 활동이 번성한 것으로 인해 향후 수년간 견고한 성장을 보일 전망입니다.
아시아태평양은 이 10년간 가장 빠른 속도로 추진할 전망입니다. 이것은 이 지역의 국내외 의료·바이오테크놀러지 기업으로부터의 자금조달이 증가하고 있기 때문입니다.
세계의 연구용 항체·시약 시장을 분석했으며, 시장의 기본 구조·최신 상황 및 주요 촉진·억제요인, 세계 전체 및 지역별·주요 국가의 시장 규모 동향 전망(금액 기반, 2017-2030년), 제품별·종류별·업종별·원료별·형상별·기술별·용도별·최종사용자별 상세 동향, 현재의 시장 경쟁 상황, 주요 기업의 개요 등을 조사하여 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 업계 전망
- 시장 역학
- 동향
- 촉진요인
- 억제요인/과제
- 촉진요인/억제요인의 영향 분석
- 신종 코로나바이러스 감염증(COVID-19)의 영향
- Porter's Five Forces 분석
제6장 세계 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시약 시장의 매출 : 종류별(2017-2030년)
- 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 업종별(2017-2030년)
- 시장 매출 : 원료별(2017-2030년)
- 시장 매출 : 형상별(2017-2030년)
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시약 시장의 매출 : 종류별(2017-2030년)
- 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 업종별(2017-2030년)
- 시장 매출 : 원료별(2017-2030년)
- 시장 매출 : 형상별(2017-2030년)
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아태평양 시장
제10장 라틴아메리카 시장
제11장 중동 및 아프리카 시장
제12장 미국 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시약 시장의 매출 : 종류별(2017-2030년)
- 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 업종별(2017-2030년)
- 시장 매출 : 원료별(2017-2030년)
- 시장 매출 : 형상별(2017-2030년)
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카공화국 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 참여 기업과 제공 제품/서비스 리스트
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근 전략 개발 상황
제30장 기업 개요
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Abcam plc
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- PerkinElmer Inc.
- Bio-Rad Laboratories Inc.
- Teva Pharmaceutical Industries Limited
- Eli Lilly and Company
- Agilent Technologies Inc.
제31장 부록
KSA 24.04.30Key Highlights
The research antibodies & reagents market generated USD 12.0 billion in 2023, and it will touch USD 18.7 billion, with a 6.7% CAGR, by 2030.
The rising need for clinical diagnostics, carrier screening, and new drugs, along with the surging incidence of genetic disorders is aiding the industry's growth.
The swift technological improvement in pharmaceutical platforms, the substantial application of antibodies & reagents in biotechnology & pharmaceutical analyses, and growing funding and initiatives from private and government bodies for large-scale biotechnology projects resulted in the industry expansion.
The rising research activities to produce new medicines, get them into trials and have them approved boost this industry.
Governments are funding in such activities because of the increasing incidence of chronic and infectious ailments, for discovering effective treatments.
Therefore, life sciences research activities have shattered some records in terms of scientific advancements, funding, and the variety and quantity of new medicines that are accessible to patients across the globe.
The market made some ground-breaking contributions during the pandemic of COVID-19 in the form of vaccines and therapeutics, assisted by the effective application of various research antibodies & reagents.
Key Insights
The reagents category accounted for the largest share of the industry in 2023, of approximately 60%, and it will continue this trend throughout this decade.
The growing application of biotechnology and biosciences in the pharmaceutical and healthcare sectors and the increasing biotechnical and pharmaceutical research for finding more effective, new drugs are driving the reagents category.
Primary antibodies led the industry in 2023, with approximately 70% share, and it will remain leading in the coming years.
The growth in the primary antibodies is because of the extensive variety of utilities offered by these antibodies in the R&D space; and the increasing availability of primary antibodies using goats, mice, rabbits, and various other species as hosts.
The oncology category was the largest contributor to the industry in 2023, with approximately 35% share, and it will remain the largest during this decade, because of the increasing incidence of cancer in key geographies.
The mice category led the industry because of the smaller size and high reproduction rate of the antibodies & reagents produced using mouse tissue.
The western blotting category is leading the market because of the extensive accessibility and acceptance of this method in healthcare R&D.
Monoclonal antibodies led the industry, due to the rising count of cancer research projects, which require antibodies with high specificity.
Proteomics was the largest contributor in 2023, with approximately 40% share, and it will further propel at a robust rate in the coming years.
The demand for greater effectiveness when mapping drug-protein and protein-protein interactions is boosting the proteomics category.
North America led the industry in 2023, with a share of approximately 55%, and it will advance at a robust rate in the coming years, owing to the substantial biotechnology and pharmaceutical R&D activities.
APAC will propel at the fastest rate during this decade, owing to the increasing funding from both foreign and domestic healthcare and biotechnology firms in this region.
The research antibodies & reagents industry is dynamic and competitive. Competition is powered by technological improvements, the specific demands of different research areas, and product innovation.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by type
- 1.4.3. Market size breakdown, by vertical
- 1.4.4. Market size breakdown, by source
- 1.4.5. Market size breakdown, by form
- 1.4.6. Market size breakdown, by technology
- 1.4.7. Market size breakdown, by application
- 1.4.8. Market size breakdown, by end user
- 1.4.9. Market size breakdown, by region
- 1.4.10. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product (2017-2030)
- 6.2.1. Reagents market revenue, by type (2017-2030)
- 6.3. Market Revenue, by Type (2017-2030)
- 6.4. Market Revenue, by Vertical (2017-2030)
- 6.5. Market Revenue, by Source (2017-2030)
- 6.6. Market Revenue, by Form (2017-2030)
- 6.7. Market Revenue, by Technology (2017-2030)
- 6.8. Market Revenue, by Application (2017-2030)
- 6.9. Market Revenue, by End User (2017-2030)
- 6.10. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.2.1. Reagents market revenue, by type (2017-2030)
- 7.3. Market Revenue, by Type (2017-2030)
- 7.4. Market Revenue, by Vertical (2017-2030)
- 7.5. Market Revenue, by Source (2017-2030)
- 7.6. Market Revenue, by Form (2017-2030)
- 7.7. Market Revenue, by Technology (2017-2030)
- 7.8. Market Revenue, by Application (2017-2030)
- 7.9. Market Revenue, by End User (2017-2030)
- 7.10. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.2.1. Reagents market revenue, by type (2017-2030)
- 8.3. Market Revenue, by Type (2017-2030)
- 8.4. Market Revenue, by Vertical (2017-2030)
- 8.5. Market Revenue, by Source (2017-2030)
- 8.6. Market Revenue, by Form (2017-2030)
- 8.7. Market Revenue, by Technology (2017-2030)
- 8.8. Market Revenue, by Application (2017-2030)
- 8.9. Market Revenue, by End User (2017-2030)
- 8.10. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.2.1. Reagents market revenue, by type (2017-2030)
- 9.3. Market Revenue, by Type (2017-2030)
- 9.4. Market Revenue, by Vertical (2017-2030)
- 9.5. Market Revenue, by Source (2017-2030)
- 9.6. Market Revenue, by Form (2017-2030)
- 9.7. Market Revenue, by Technology (2017-2030)
- 9.8. Market Revenue, by Application (2017-2030)
- 9.9. Market Revenue, by End User (2017-2030)
- 9.10. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.2.1. Reagents market revenue, by type (2017-2030)
- 10.3. Market Revenue, by Type (2017-2030)
- 10.4. Market Revenue, by Vertical (2017-2030)
- 10.5. Market Revenue, by Source (2017-2030)
- 10.6. Market Revenue, by Form (2017-2030)
- 10.7. Market Revenue, by Technology (2017-2030)
- 10.8. Market Revenue, by Application (2017-2030)
- 10.9. Market Revenue, by End User (2017-2030)
- 10.10. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.2.1. Reagents market revenue, by type (2017-2030)
- 11.3. Market Revenue, by Type (2017-2030)
- 11.4. Market Revenue, by Vertical (2017-2030)
- 11.5. Market Revenue, by Source (2017-2030)
- 11.6. Market Revenue, by Form (2017-2030)
- 11.7. Market Revenue, by Technology (2017-2030)
- 11.8. Market Revenue, by Application (2017-2030)
- 11.9. Market Revenue, by End User (2017-2030)
- 11.10. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.2.1. Reagents market revenue, by type (2017-2030)
- 12.3. Market Revenue, by Type (2017-2030)
- 12.4. Market Revenue, by Vertical (2017-2030)
- 12.5. Market Revenue, by Source (2017-2030)
- 12.6. Market Revenue, by Form (2017-2030)
- 12.7. Market Revenue, by Technology (2017-2030)
- 12.8. Market Revenue, by Application (2017-2030)
- 12.9. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.2.1. Reagents market revenue, by type (2017-2030)
- 13.3. Market Revenue, by Type (2017-2030)
- 13.4. Market Revenue, by Vertical (2017-2030)
- 13.5. Market Revenue, by Source (2017-2030)
- 13.6. Market Revenue, by Form (2017-2030)
- 13.7. Market Revenue, by Technology (2017-2030)
- 13.8. Market Revenue, by Application (2017-2030)
- 13.9. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.2.1. Reagents market revenue, by type (2017-2030)
- 14.3. Market Revenue, by Type (2017-2030)
- 14.4. Market Revenue, by Vertical (2017-2030)
- 14.5. Market Revenue, by Source (2017-2030)
- 14.6. Market Revenue, by Form (2017-2030)
- 14.7. Market Revenue, by Technology (2017-2030)
- 14.8. Market Revenue, by Application (2017-2030)
- 14.9. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.2.1. Reagents market revenue, by type (2017-2030)
- 15.3. Market Revenue, by Type (2017-2030)
- 15.4. Market Revenue, by Vertical (2017-2030)
- 15.5. Market Revenue, by Source (2017-2030)
- 15.6. Market Revenue, by Form (2017-2030)
- 15.7. Market Revenue, by Technology (2017-2030)
- 15.8. Market Revenue, by Application (2017-2030)
- 15.9. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.2.1. Reagents market revenue, by type (2017-2030)
- 16.3. Market Revenue, by Type (2017-2030)
- 16.4. Market Revenue, by Vertical (2017-2030)
- 16.5. Market Revenue, by Source (2017-2030)
- 16.6. Market Revenue, by Form (2017-2030)
- 16.7. Market Revenue, by Technology (2017-2030)
- 16.8. Market Revenue, by Application (2017-2030)
- 16.9. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.2.1. Reagents market revenue, by type (2017-2030)
- 17.3. Market Revenue, by Type (2017-2030)
- 17.4. Market Revenue, by Vertical (2017-2030)
- 17.5. Market Revenue, by Source (2017-2030)
- 17.6. Market Revenue, by Form (2017-2030)
- 17.7. Market Revenue, by Technology (2017-2030)
- 17.8. Market Revenue, by Application (2017-2030)
- 17.9. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.2.1. Reagents market revenue, by type (2017-2030)
- 18.3. Market Revenue, by Type (2017-2030)
- 18.4. Market Revenue, by Vertical (2017-2030)
- 18.5. Market Revenue, by Source (2017-2030)
- 18.6. Market Revenue, by Form (2017-2030)
- 18.7. Market Revenue, by Technology (2017-2030)
- 18.8. Market Revenue, by Application (2017-2030)
- 18.9. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.2.1. Reagents market revenue, by type (2017-2030)
- 19.3. Market Revenue, by Type (2017-2030)
- 19.4. Market Revenue, by Vertical (2017-2030)
- 19.5. Market Revenue, by Source (2017-2030)
- 19.6. Market Revenue, by Form (2017-2030)
- 19.7. Market Revenue, by Technology (2017-2030)
- 19.8. Market Revenue, by Application (2017-2030)
- 19.9. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.2.1. Reagents market revenue, by type (2017-2030)
- 20.3. Market Revenue, by Type (2017-2030)
- 20.4. Market Revenue, by Vertical (2017-2030)
- 20.5. Market Revenue, by Source (2017-2030)
- 20.6. Market Revenue, by Form (2017-2030)
- 20.7. Market Revenue, by Technology (2017-2030)
- 20.8. Market Revenue, by Application (2017-2030)
- 20.9. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.2.1. Reagents market revenue, by type (2017-2030)
- 21.3. Market Revenue, by Type (2017-2030)
- 21.4. Market Revenue, by Vertical (2017-2030)
- 21.5. Market Revenue, by Source (2017-2030)
- 21.6. Market Revenue, by Form (2017-2030)
- 21.7. Market Revenue, by Technology (2017-2030)
- 21.8. Market Revenue, by Application (2017-2030)
- 21.9. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.2.1. Reagents market revenue, by type (2017-2030)
- 22.3. Market Revenue, by Type (2017-2030)
- 22.4. Market Revenue, by Vertical (2017-2030)
- 22.5. Market Revenue, by Source (2017-2030)
- 22.6. Market Revenue, by Form (2017-2030)
- 22.7. Market Revenue, by Technology (2017-2030)
- 22.8. Market Revenue, by Application (2017-2030)
- 22.9. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.2.1. Reagents market revenue, by type (2017-2030)
- 23.3. Market Revenue, by Type (2017-2030)
- 23.4. Market Revenue, by Vertical (2017-2030)
- 23.5. Market Revenue, by Source (2017-2030)
- 23.6. Market Revenue, by Form (2017-2030)
- 23.7. Market Revenue, by Technology (2017-2030)
- 23.8. Market Revenue, by Application (2017-2030)
- 23.9. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.2.1. Reagents market revenue, by type (2017-2030)
- 24.3. Market Revenue, by Type (2017-2030)
- 24.4. Market Revenue, by Vertical (2017-2030)
- 24.5. Market Revenue, by Source (2017-2030)
- 24.6. Market Revenue, by Form (2017-2030)
- 24.7. Market Revenue, by Technology (2017-2030)
- 24.8. Market Revenue, by Application (2017-2030)
- 24.9. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.2.1. Reagents market revenue, by type (2017-2030)
- 25.3. Market Revenue, by Type (2017-2030)
- 25.4. Market Revenue, by Vertical (2017-2030)
- 25.5. Market Revenue, by Source (2017-2030)
- 25.6. Market Revenue, by Form (2017-2030)
- 25.7. Market Revenue, by Technology (2017-2030)
- 25.8. Market Revenue, by Application (2017-2030)
- 25.9. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.2.1. Reagents market revenue, by type (2017-2030)
- 26.3. Market Revenue, by Type (2017-2030)
- 26.4. Market Revenue, by Vertical (2017-2030)
- 26.5. Market Revenue, by Source (2017-2030)
- 26.6. Market Revenue, by Form (2017-2030)
- 26.7. Market Revenue, by Technology (2017-2030)
- 26.8. Market Revenue, by Application (2017-2030)
- 26.9. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.2.1. Reagents market revenue, by type (2017-2030)
- 27.3. Market Revenue, by Type (2017-2030)
- 27.4. Market Revenue, by Vertical (2017-2030)
- 27.5. Market Revenue, by Source (2017-2030)
- 27.6. Market Revenue, by Form (2017-2030)
- 27.7. Market Revenue, by Technology (2017-2030)
- 27.8. Market Revenue, by Application (2017-2030)
- 27.9. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.2.1. Reagents market revenue, by type (2017-2030)
- 28.3. Market Revenue, by Type (2017-2030)
- 28.4. Market Revenue, by Vertical (2017-2030)
- 28.5. Market Revenue, by Source (2017-2030)
- 28.6. Market Revenue, by Form (2017-2030)
- 28.7. Market Revenue, by Technology (2017-2030)
- 28.8. Market Revenue, by Application (2017-2030)
- 28.9. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Thermo Fisher Scientific Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Merck KGaA
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Abcam plc
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Becton, Dickinson and Company
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. F. Hoffmann-La Roche Ltd.
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. PerkinElmer Inc.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Bio-Rad Laboratories Inc.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Teva Pharmaceutical Industries Limited
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Eli Lilly and Company
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Agilent Technologies Inc.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
